CSTL
CSTL
US14843C1053
Castle Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.05B EUR
727.63M EUR
743.77M EUR
1.15B EUR
Enterprise Value
799.67M EUR
702.16M EUR
716.73M EUR
1.07B EUR
Valuation Multiples
Trailing P/E
--
--
--
683.31x
Forward P/E
-36.66x
--
--
--
Price to Sales
2.94x
2.04x
2.19x
4.51x
Price to Book
2.23x
1.55x
1.61x
2.45x
EV/Revenue
2.24x
1.97x
2.11x
4.2x
EV/EBITDA
-48.42x
--
--
217.52x
Price to FCF (P/FCF)
--
--
164.62x
29.53x
EV/FCF
--
--
158.64x
27.49x
FCF Yield
-0.69%
-0.07%
0.61%
3.39%
ende